Akari Therapeutcis (AKTX) Reports In-Line Q1 EPS
Tweet
Share
E-mailGet Alerts AKTX Hot Sheet
Join SI Premium – FREE
Akari Therapeutcis (NASDAQ: AKTX) reported Q1 EPS of $0.00.
For earnings history and earnings-related data on Akari Therapeutcis (AKTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
- Jefferies Starts Freenome Inc. (FRNM) at Buy
- Jefferies Downgrades BSE Limited (BSE:IN) to Underperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
